ConductScience.org, home

Paper8098047

Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.

Hait WN and 3 others. J Clin Invest, 1993. Cited by 35 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents. Papers, record 8098047. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8098047

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.
PubMed
Journal
J Clin Invest
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
0.92
iCite
Revised in PubMed
2018-11-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hait WNW N
2Choudhury SS
3Srimatkandada SS
4Murren JRJ R

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CyclosporineMajor topic
Drug ResistanceMajor topic
FlupenthixolMajor topic
Membrane GlycoproteinsMajor topic
VinblastineMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Blotting, Southern
Cell Differentiation
Cytarabine
DNA
Gene Expression
Hemin
Humans
Kinetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
RNA, Messenger
Transfection
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 08341NCI NIH HHSUnited StatesP01CA008341PubMed and NIHNIH RePORTER
CA 43888NCI NIH HHSUnited StatesR01CA043888PubMed and NIHNIH RePORTER
P02CA008341NIHNIH RePORTER

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14005839Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.Cancer Res1985https://conductscience.org/library/papers/4005839PubMed
22892823Detection of multidrug resistance markers, P-glycoprotein and mdr1 mRNA, in human leukemia cells.Jpn J Cancer Res1987https://conductscience.org/library/papers/2892823PubMed
32898143A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2898143PubMed
43165724Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3165724PubMed
53045133Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids.J Cell Physiol1988https://conductscience.org/library/papers/3045133PubMed
62562856Expression of a multidrug resistance gene in human cancers.J Natl Cancer Inst1989https://conductscience.org/library/papers/2562856PubMed
72535960Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.Cancer Res1989https://conductscience.org/library/papers/2535960PubMed
82910487Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.Cancer Res1989https://conductscience.org/library/papers/2910487PubMed
92563302Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.Mol Pharmacol1989https://conductscience.org/library/papers/2563302PubMed
102804973Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.Cancer Res1989https://conductscience.org/library/papers/2804973PubMed
112572588Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents.J Biol Chem1989https://conductscience.org/library/papers/2572588PubMed
121967174Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells.J Biol Chem1990https://conductscience.org/library/papers/1967174PubMed
131968358Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.Cancer Res1990https://conductscience.org/library/papers/1968358PubMed
142576973Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.Cancer Commun1989https://conductscience.org/library/papers/2576973PubMed
152640154Activity of cyclosporin A and a non-immunosuppressive cyclosporin against multidrug resistant leukemic cell lines.Cancer Commun1989https://conductscience.org/library/papers/2640154PubMed
162217530Pharmacology of drugs that alter multidrug resistance in cancer.Pharmacol Rev1990https://conductscience.org/library/papers/2217530PubMed
171703776Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells.Cell Growth Differ1990https://conductscience.org/library/papers/1703776PubMed
181676843Multidrug-resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation.Prog Clin Biol Res1991https://conductscience.org/library/papers/1676843PubMed
191349840Why haven't we cured multidrug resistant tumors?Oncol Res1992https://conductscience.org/library/papers/1349840PubMed
201360276Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.Oncol Res1992https://conductscience.org/library/papers/1360276PubMed

See all 38 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
39314886Feeder cell training shapes the phenotype and function of in vitro expanded natural killer cells.MedComm (2020)2024https://conductscience.org/library/papers/39314886PubMed
30857233Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling.Cancers (Basel)2019https://conductscience.org/library/papers/30857233PubMed
29363591Topoisomerases as anticancer targets.Biochem J2018https://conductscience.org/library/papers/29363591PubMed
28450921Research on the effect of ginseng polysaccharide on apoptosis and cell cycle of human leukemia cell line K562 and its molecular mechanisms.Exp Ther Med2017https://conductscience.org/library/papers/28450921PubMed
25360237Practical management of patients with chronic myeloid leukemia who develop tyrosine kinase inhibitor-resistant BCR-ABL1 mutations.Ther Adv Hematol2014https://conductscience.org/library/papers/25360237PubMed
24070327Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?Biosci Rep2013https://conductscience.org/library/papers/24070327PubMed
23263730Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate.J Radiat Res2013https://conductscience.org/library/papers/23263730PubMed
20938465Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype.Pharmacogenomics J2012https://conductscience.org/library/papers/20938465PubMed
19762091Is resistance useless? Multidrug resistance and collateral sensitivity.Trends Pharmacol Sci2009https://conductscience.org/library/papers/19762091PubMed
7765329Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.Cytotechnology1993https://conductscience.org/library/papers/7765329PubMed
7765325Pharmacologic circumvention of multidrug resistance.Cytotechnology1993https://conductscience.org/library/papers/7765325PubMed
7636888Drug-transport and volume-activated chloride channel functions in human erythroleukemia cells: relation to expression level of P-glycoprotein.J Membr Biol1995https://conductscience.org/library/papers/7636888PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8098047

GET https://conductscience.org/api/papers/v1/8098047/references?page=2